Wanbury Limited

Healthcare · Pharmaceuticals & Biotechnology

NSE: WANBURY BSE: 524212

About Wanbury Limited

No company profile on record yet.

Key facts

BSE symbol524212
NSE symbolWANBURY
ISININE107F01022
CINL51900MH1988PLC048455
Listing date29 Jan 2007
Fiscal year end31 Mar
SectorHealthcare
IndustryPharmaceuticals & Biotechnology
AuditorKALA AGARWAL (KALA AGARWAL)
Registered officeBSEL Tech Park, 'B; Wing, 10th Floor, Sector 30A, Opp.Vashi Railway Station, Vashi, New Mumbai, 400703
Registrar & transfer agentPURVA SHAREGISTRY (INDIA) P LTD (BUSICOMP SOFTWARE CONSULTANTS NO-9, SHIV SHAKTI INDUSTRIAL ESTATE, J. R. BORICHA MARG, LOWER PAREL (EAST)

Financial performance

Full financials →
Fiscal yearMar 26Mar 25Mar 24Mar 23Mar 22
Total income (before exceptional items)651†605†579†501†513†
Net profit663130-1081†

₹ Crore. † Summed from the four quarterly filings of that fiscal year.

Board of directors

Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.

NameDesignationTerm end
CHANDRAN KRISHNAMOORTHYExecutive DirectorJune 30, 2026
MOHAN KUMAR RAYANAExecutive DirectorJune 30, 2026
ANUPAMA VAIDYAIndependent DirectorJune 30, 2026
MANOJKUMAR KHUBCHAND GURSAHANIIndependent DirectorJune 30, 2026
MRIDUL SUMANLAL MEHTAIndependent DirectorJune 30, 2026
PALLAVUR SANKAR DASS VAIDYANATHANIndependent DirectorJune 30, 2026

Management, subsidiaries and brands

Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.